NTLA Intellia Therapeutics Inc gains 15% Mar 22, 2019

Intellia Therapeutics Inc., a gene editing company, focuses on the development of therapeutics utilizing a biological tool known as the CRISPR/Cas9 system. The company develops in vivo programs focused on liver diseases, including transthyretin amyloidosis, alpha-1 antitrypsin deficiency, hepatitis B virus, and inborn errors of metabolism; and ex vivo applications of the technology in chimeric antigen receptor T cell and hematopoietic stem cell product candidates. It has a strategic collaboration and license agreement with Novartis focused on the development of new ex vivo CRISPR/Cas9-based therapies. Intellia Therapeutics Inc. was formerly known as AZRN, Inc. and changed its name to Intellia Therapeutics Inc. in July 2014. The company was founded in 2014 and is headquartered in Cambridge, Massachusetts.http://www.priceseries.com/trade/NTLA-Intellia-Therapeutics-Inc-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2019022520190322.html

LMAT LeMaitre Vascular, Inc. gains 26% Mar 22, 2019

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. The company provides angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; carotid shunts to temporarily divert or shut blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and powered phlebectomy devices that enable removal of varicose veins. It also offers embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude blood flow; and perfusion catheters that temporarily perfuse blood and other liquids into the vasculature. In addition, the company provides radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin; and remote endarterectomy devices to remove plaque from arteries in the leg. Further, it offers valvulotomes that cuts valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; vascular grafts to bypass or replace diseased arteries; vascular patches, which are used for precision endarterectomy vascular reconstruction; vessel closure systems to attach vessels to one another with titanium clips instead of sutures; and laparoscopic cholecystectomy devices to inject dye into the cystic duct during laparoscopic cholecystectomy, as well as laparoscopic accessory for use in laparoscopic gall bladder removal. LeMaitre Vascular, Inc. markets its products through direct and indirect sales force. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was founded in 1983 and is headquartered in Burlington, Massachusetts.http://www.priceseries.com/trade/LMAT-LeMaitre-Vascular-Inc-stock-gains-26-percent-a-Trade-Record-by-priceSeries-2019021120190322.html

IMMU Immunomedics, Inc. gains 18% Mar 22, 2019

Immunomedics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune disorders, and other diseases. The company engages in developing antibody-drug conjugate (ADC) products comprising IMMU-132, an ADC that contains SN-38, which is in Phase II trials used for the treatment of patients with metastatic triple-negative breast cancer, and small-cell and non-small-cell lung cancers; IMMU-130, an anti-CEACAN5-SN-38 ADC that is in Phase II trials for the treatment of solid tumors and metastatic colorectal cancer; and epratuzumab, a humanized antibody that targets CD22, an antigen found on the surface of B lymphocytes. Its early-stage products include IMMU-114, a novel humanized antibody for the treatment of patients with B-cell and other cancers; Milatuzumab, a humanized monoclonal antibody targeting tumors that expresses the CD74 antigen, which is present on various hematological tumors and solid cancers; Veltuzumab, a humanized monoclonal antibody targeting CD20 receptors on B lymphocytes for the treatment of non-Hodgkin lymphoma and autoimmune diseases; and Yttrium-90-Labeled Epratuzumab Tetraxetan, a radiolabeled anti-CD22 investigational product. The company also provides LeukoScan, a diagnostic imaging product for diagnostic imaging to determine the location and extent of infection/inflammation in bone. In addition, it offers other product candidates for the treatment of solid tumors and hematologic malignancies, as well as other diseases, which are in various stages of clinical and pre-clinical development. The company has a research collaboration with The Bayer Group to study epratuzumab as a thorium-227-labeled antibody. Immunomedics, Inc. was founded in 1982 and is headquartered in Morris Plains, New Jersey.http://www.priceseries.com/trade/IMMU-Immunomedics-Inc-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2019022220190322.html

FSCT ForeScout Technologies, Inc. gains 58% Mar 22, 2019

http://www.priceseries.com/trade/FSCT-ForeScout-Technologies-Inc-stock-gains-58-percent-a-Trade-Record-by-priceSeries-2019012320190322.html

ECL Ecolab Inc. gains 18% Mar 22, 2019

Ecolab Inc. provides water, hygiene, and energy technologies and services for customers worldwide. The company operates in three segments: Global Industrial, Global Institutional, and Global Energy. The Global Industrial segment provides water treatment and process applications, and cleaning and sanitizing solutions primarily to large industrial customers within the manufacturing, food and beverage processing, chemical, mining and primary metals, power generation, pulp and paper, and commercial laundry industries. The Global Institutional segment offers specialized cleaning and sanitizing products to the foodservice, hospitality, lodging, healthcare, government and education, and retail industries. The Global Energy segment provides the process chemicals and water treatment needs of the petroleum and petrochemical industries in upstream and downstream applications. The company also offers pest elimination services to detect, eliminate, and prevent pests, such as rodents and insects, in restaurants, food and beverage processors, educational and healthcare facilities, hotels, quick service restaurant and grocery operations, and other institutional and commercial customers; and equipment repair, maintenance, and preventive maintenance services for the commercial food service industry. Ecolab Inc. sells its products through field sales personnel, corporate account personnel, distributors, and dealers. Ecolab Inc. was founded in 1923 and is headquartered in St. Paul, Minnesota.http://www.priceseries.com/trade/ECL-Ecolab-Inc-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2019010420190322.html

DBD Diebold, Incorporated gains 153% Mar 22, 2019

Diebold Nixdorf, Incorporated provides connected commerce services, software, and technology for financial, commercial, and industrial customers. The company operates in four segments: North America; Asia Pacific; Europe, Middle East and Africa; and Latin America. It offers financial self-service solutions and technologies, including automated teller machine (ATM) outsourcing, ATM security, deposit automation, recycling and payment terminals, and software. The company also provides financial self-service support and maintenance services comprising installation and ongoing maintenance of products, availability management, branch automation, and distribution channel consulting; outsourced and managed services, such as remote monitoring, troubleshooting, transaction processing, currency management, maintenance, and online communication services; and strategic analysis and planning for new systems, systems integration, architectural engineering, consulting, and project management services, as well as multi-vendor services. In addition, it offers electronic security services and products; security monitoring solutions comprising remote monitoring and diagnostics, fire detection, intrusion protection, managed access control, energy management, remote video management and storage, logical security, and Web-based solutions; and physical security and facility products. Further, the company provides development, training, support, and maintenance of elections and lottery equipment, networking, tabulation, and diagnostic software; and IT solutions and services to retail banks and the retail industry. The company was formerly known as Diebold, Incorporated and changed its name to Diebold Nixdorf, Incorporated in December 2016. Diebold Nixdorf, Incorporated was founded in 1859 and is headquartered in North Canton, Ohio.http://www.priceseries.com/trade/DBD-Diebold-Incorporated-stock-gains-153-percent-a-Trade-Record-by-priceSeries-2019013120190322.html

CTRP Ctrip.com International, Ltd. gains 18% Mar 22, 2019

Ctrip.com International, Ltd., together with its subsidiaries, provides travel service for accommodation reservation, transportation ticketing, packaged tours, and corporate travel management in the People's Republic of China. The company operates as an agent for hotel-related transactions; sells air tickets; and other related services, including sale of aviation and train insurance, air-ticket delivery services, online check-in, and other value-added services, such as online seat selection and flight dynamics. It also provides independent leisure travelers bundled packaged-tour products comprising group tours, semi-group tours, and customized tours and packaged tours with various transportation arrangements, such as flights, cruises, and buses, as well as car rental services. In addition, the company offers integrated transportation and accommodation services; various value-added services, such as transportation at destinations and tickets, insurance, visa services, and tour guides; and supplier management and customer relationship management services. Further, it provides travel data collection and analysis, industry benchmark, cost saving analysis, and travel management solutions; and Corporate Travel Management System, an online platform that integrates information maintenance, online booking and authorization, online enquiry, and travel report system. Additionally, the company offers online advertising services; and sells Property Management System, as well as provides related maintenance services. Ctrip.com International, Ltd. was founded in 1999 and is headquartered in Shanghai, the People's Republic of China.http://www.priceseries.com/trade/CTRP-Ctripcom-International-Ltd-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2019022820190322.html

CRAI CRA International,Inc. gains 18% Mar 22, 2019

CRA International, Inc., a consulting company, provides economic, financial, and management consulting services worldwide. The company advises clients on economic and financial matters pertaining to litigation and regulatory proceedings; and guides corporations through critical business strategy and performance-related issues. It provides consulting services, including research and analysis, expert testimony, and support in litigation and regulatory proceedings in the areas of finance, accounting, economics, insurance, and forensic accounting and investigations to corporate clients and attorneys. The company also offers services related to class certification, damages analysis, expert reports and testimony, regulatory analysis, strategy development, valuation of tangible and intangible assets, risk management, and transaction support to law firms, businesses, and government agencies. In addition, it provides management consulting services, such as strategy development, performance improvement, corporate strategy and portfolio analysis, estimation of market demand, new product pricing strategies, valuation of intellectual property and other assets, assessment of competitors' actions, and analysis of new sources of supply. The company serves various industries, including agriculture; banking and capital markets; chemicals; communications and media; consumer products; energy; entertainment; financial services; health care; insurance; life sciences; manufacturing; metals, mining, and materials; oil and gas; real estate; retail; sports; telecommunications; transportation; and technology. Further, it develops and markets neural network software tools, as well as provides complementary application consulting services primarily for electric utilities. CRA International, Inc. was founded in 1965 and is headquartered in Boston, Massachusetts.http://www.priceseries.com/trade/CRAI-CRA-InternationalInc-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2019021420190322.html

BOLD Audentes Therapeutics Inc gains 50% Mar 22, 2019

Audentes Therapeutics, Inc., a biotechnology company, focuses on developing and commercializing gene therapy products for patients suffering from diseases caused by single gene defects in the United States. The company is developing four products, including AT132 for the treatment of X-linked myotubular myopathy; AT342 for the treatment of crigler-najjar syndrome type 1; AT307 for the treatment of the CASQ2 subtype of catecholaminergic polymorphic ventricular tachycardia; and AT982 for the treatment of pompe disease. Audentes Therapeutics, Inc. has a collaboration with the University of Pennsylvania to develop AT342, an AAV gene therapy for Crigler-Najjar Syndrome, an inherited, metabolic liver disease. The company was founded in 2012 and is based in San Francisco, California.http://www.priceseries.com/trade/BOLD-Audentes-Therapeutics-Inc-stock-gains-50-percent-a-Trade-Record-by-priceSeries-2019021520190322.html

BIO Bio-Rad Laboratories, Inc. gains 21% Mar 22, 2019

Bio-Rad Laboratories, Inc. manufactures and supplies products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components for life science research, healthcare, analytical chemistry, and other markets. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls that serve clinical laboratories in the diagnostics market. Its products include reagents, instruments, and software which address specific niches within the in vitro diagnostics (IVD) test market. This segment sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. It operates in Europe, Pacific Rim, the United States, and internationally. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.http://www.priceseries.com/trade/BIO-Bio-Rad-Laboratories-Inc-stock-gains-21-percent-a-Trade-Record-by-priceSeries-2019021120190322.html